Lexaria now has 60 patents granted around much of the world Lexaria urges shareholders to vote at upcoming 2026 Annual Meeting   Kelowna, British Columbia – January 22, 2026 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce it has reached yet another important milestone in its strategy of building a strong and diverse intellectual property portfolio: the Company now has a total of 60 valid patents ...